Skip to main content
Premium Trial:

Request an Annual Quote

Covance, ISB Partner on Brain Tumor Biology Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Contract research organization Covance today announced a collaboration between its genomics laboratory in Seattle and the Institute for Systems Biology to further research into brain tumor biology.

Specifically, Covance's expertise in genomics assays and ISB's expertise in complex genomic networks will be leveraged to unravel the regulation of gene expression in glioblastoma multiforme.

The partners will perform next-generation sequencing to generate datasets, which will be used by researchers to investigate tumor heterogeneity and to find targets for patient stratification and/or therapeutics, Covance said. The goal is to provide a high-quality map of gene expression and RNA structure to enable research into brain tumor biology, it added.

Financial and other terms of the deal were not disclosed.

"The ability to resolve complex regulatory networks requires reproducible, high-quality data," Lee Hood, president of ISB, said in a statement. "We know Covance's experience in genomics and next-generation sequencing will give us an unprecedented level of high-quality data."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.